Ginés-Rosario Mariela, Lopez-Pena Belissa, Piñeiro Zydnia, Perez-Mitchell Maria C, Fernandez-Gonzalez Ricardo
Internal Medicine, San Juan City Hospital, San Juan, PRI.
Pulmonary and Critical Care Medicine, San Juan City Hospital, San Juan, PRI.
Cureus. 2025 Aug 10;17(8):e89713. doi: 10.7759/cureus.89713. eCollection 2025 Aug.
Mixed phenotype acute leukemia (MPAL) is a rare and diagnostically challenging hematologic malignancy characterized by the co-expression of myeloid and lymphoid lineage markers. We present the case of a 61-year-old woman with newly diagnosed MPAL who developed diffuse alveolar hemorrhage (DAH) shortly after induction chemotherapy. Despite aggressive supportive care, including bronchoscopy-guided diagnosis, high-dose corticosteroids, antifibrinolytics, and lung-protective ventilation with prone positioning, her condition rapidly deteriorated into multi-organ failure and death. This case highlights the need for early recognition of pulmonary complications in high-risk leukemias and underscores the limitations of current management strategies in the setting of DAH complicating MPAL.
混合表型急性白血病(MPAL)是一种罕见且诊断具有挑战性的血液系统恶性肿瘤,其特征是髓系和淋巴系标志物的共表达。我们报告了一例61岁新诊断为MPAL的女性患者,在诱导化疗后不久发生了弥漫性肺泡出血(DAH)。尽管给予了积极的支持治疗,包括支气管镜引导下诊断、大剂量皮质类固醇、抗纤维蛋白溶解剂以及采用俯卧位的肺保护性通气,但她的病情迅速恶化为多器官功能衰竭并死亡。该病例凸显了在高危白血病中早期识别肺部并发症的必要性,并强调了在MPAL合并DAH情况下当前管理策略的局限性。